Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy

Psychopharmacology

Volumn 171, Issue 2, 2004, Pages 133-139

  Becker, Philip M ^a,e   Schwartz, Jonathan R L ^b   Feldman, Neil T ^c   Hughes, Rod J ^d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Integris Sleep Disord Ctr Oklahoma   (United States)

^c St Petersburg Sleep Disord Center   (United States)

^d CEPHALON INC   (United States)

^e Sleep Medicine Associates of Texas PA   (United States)

Author keywords

Cognition; Fatigue; Modafinil; Mood; Narcolepsy; Quality of life

Indexed keywords

DEXAMPHETAMINE; METHYLPHENIDATE; MODAFINIL; PEMOLINE; PSYCHOSTIMULANT AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COGNITION; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; HEADACHE; HEALTH SURVEY; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MOOD; MULTICENTER STUDY; NARCOLEPSY; NAUSEA; OUTPATIENT CARE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; SIDE EFFECT; SOCIAL ASPECT; SOMNOLENCE; THOUGHT DISORDER; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AFFECT; AGED; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; NARCOLEPSY; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; TREATMENT OUTCOME; WAKEFULNESS;

EID: 1542707885     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1508-9     Document Type: Article

References (30)

1. American Sleep Disorders Association (1997) The international classification of sleep disorders, revised. Diagnostic and coding manual. American Sleep Disorders Association, Rochester, Minn.
2. Baranski J, Cian C, Esquivie D et al. (1998) Modafinil during 64 hr of sleep deprivation: dose-related effects on fatigue, alertness, and cognitive performance. Milit Psychol 10:173-193
3. Beusterien KM, Rogers AE, Walsleben JA, Emsellem HA, Reblando JA, Wang L, Goswami M, Steinwald B (1999) Health-related quality of life effects of modafinil for treatment of narcolepsy. Sleep 22:757-765
4. Broughton R, Ghanem Q, Hishikawa Y, Sugita Y, Nevsimalova S, Roth B (1981) Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls. Can J Neurol Sci 8:299-304
5. Broughton RJ, Fleming JAE, George CFP, Hill JD, Kryger MH, Moldofsky H, Montplaisir JY, Morehouse RL, Moscovitch A, Murphy WF (1997) Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology 49:444-451
6. Douglas NJ (1998) The psychosocial aspects of narcolepsy. Neurology 50:S27-S30
7. Goswami M (1998) The influence of clinical symptoms on quality of life in patients with narcolepsy. Neurology 50:S31-S36
8. Guy W (1976) ECDEU Assessment manual for psychopharmacology, revised. US Department of Health, Education, and Welfare, Rockville, Md.
9. Holland JC, Korzun AH, Tross S (1986) Comparative psychological disturbance in patients with pancreatic and gastric cancer. Am J Psychiatry 143:982-986
10. Horrigan JP, Barnhill LJ (2000) Low-dose amphetamine salts and adult attention-deficit/hyperactivity disorder. J Clin Psychiatry 61:414-417
11. Hublin C, Partinen M, Kaprio J, Koskenvuo M, Guilleminault C (1994) Epidemiology of narcolepsy. Sleep 17:S7-S12
12. Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 14:540-545
13. Krishnan RR, Volow MR, Miller PP, Carwile ST (1984) Narcolepsy: preliminary retrospective study of psychiatric and psychosocial aspects. Am J Psychiatry 141:428-431
14. Lin L, Hungs M, Mignot E (2001) Narcolepsy and the HLA region. J Neuroimmunol 117:9-20
15. Lorr M, McNair DM, Weinstein GJ (1964) Early effects of chlordiazepoxide (Librium) used with psychotherapy. J Psychiatr Res 1:257-270
16. McHorney CA, Ware JE Jr, Raczek AE (1993) The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31:247-263
17. McHorney CA, Ware JE Jr, Lu JFR, Sherbourne CD (1994) The MOS 36-Item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32:40-66
18. McNair DM, Lorr M, Droppleman LF (1992) Profile of Mood States (POMS) manual. Educational and Industrial Testing Service, San Diego, Calif.
19. Mignot E, Lammers GJ, Ripley B, Okum M, Nevsimalova S, Overeem S, Vankova J, Black J, Harsh J, Bassetti C, Schrader H, Nishino S (2002) The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 59:1553-1562
20. Mosko S, Zetin M, Glen S, Garber D, DeAntonio M, Sassin J, McAnich J, Warren S (1989) Self-reported depressive symptomatology, mood ratings, and treatment outcome in sleep disorders patients. J Clin Psychol 45:51-60
21. Palfai T, Jankiewicz H (1991) Amphetamine and cocaine. In: Ring DM (ed) Drugs and human behavior. Brown, Dubuque, pp 281-309
22. Pigeau R, Naitoh P, Buguet A, McCann C, Baranski J, Taylor M, Thompson M, Mack II (1995) Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature. J Sleep Res 4:212-228
23. Roy A (1976) Psychiatric aspects of narcolepsy. Br J Psychiatry 128:562-565
24. Schwartz J, Feldman N, Fry J, et al (2003) Efficacy and safety of modafinil for improving daytime wakefulness in patients treated previously with psychostimulants. Sleep Med 4:43-49
25. Stivalet P, Esquivié D, Barraud P-A, Leifflen D, Raphel C (1998) Effects of modafinil on attentional processes during 60 hours of sleep deprivation. Hum Psychopharmacol Clin Exp 13:501-507
26. Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ (2003) Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology 165:260-269
27. US Modafinil in Narcolepsy Multicenter Study Group (1998) Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol 43:88-97
28. US Modafinil in Narcolepsy Multicenter Study Group (2000) Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology 54:1166-1175
29. Ware JE Jr, Sherbourne CD (1992) The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 30:473-483
30. Ware JE, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A (1995) Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 33: AS264-A279